Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T.MAN Pharmaceutical PCLBKK:TMAN -0.88%21 FCF Margin % is 19.18% as of Mar. 2026, which is 105% above its 10-year median of 9.36. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 963 Drug Manufacturers companies, T.MAN Pharmaceutical PCL ranks better than 52.75% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TMAN vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, T.MAN Pharmaceutical PCL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T.MAN Pharmaceutical PCL FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, T.MAN Pharmaceutical PCL's FCF Margin % distribution charts can be found below:
* The bar in red indicates where T.MAN Pharmaceutical PCL's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL (BKK:TMAN) has a FCF Margin % of 19.18% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on T.MAN Pharmaceutical PCL and its competitors. This is 105% above median its historical median of 9.36. Over the past decade, T.MAN Pharmaceutical PCL's FCF Margin % has ranged from 3.15 to 15.62. According to the industry distribution chart, T.MAN Pharmaceutical PCL ranks #455 out of 963 companies in the Drug Manufacturers industry, placing it in the top 47.2%.
Is T.MAN Pharmaceutical PCL's FCF Margin % too high?
T.MAN Pharmaceutical PCL's current FCF Margin % of 19.18% is 105% above median its 10-year median of 9.36. Over the past 10 years, this metric has ranged from a low of 3.15 to a high of 15.62. The Drug Manufacturers industry median FCF Margin % is 2.57. T.MAN Pharmaceutical PCL's value of 19.18% is 646.3% above this industry median. Based on the distribution chart, T.MAN Pharmaceutical PCL ranks #455 out of 963 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, T.MAN Pharmaceutical PCL ranks #455 out of 963 companies for FCF Margin %. This puts T.MAN Pharmaceutical PCL in the upper half of its industry. The industry median FCF Margin % is 2.57. T.MAN Pharmaceutical PCL's value of 19.18% is 646.3% above this benchmark. Historically, T.MAN Pharmaceutical PCL's own FCF Margin % has ranged from 3.15 to 15.62 over the past decade. While the company's 10-year median is 9.36 vs. the industry median of 2.57, T.MAN Pharmaceutical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.57, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T.MAN Pharmaceutical PCL's current FCF Margin % of 19.18% is 646.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on T.MAN Pharmaceutical PCL and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T.MAN Pharmaceutical PCL's current FCF Margin % is 19.18%, which is 105% above median its own 10-year median of 9.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current FCF Margin % of 19.18%. The current FCF Margin % is 19.18%, which is 105% above median its 10-year median of 9.36 and 646.3% above the Drug Manufacturers industry median of 2.57. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current FCF Margin % is 19.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score
Get the complete analysis for BKK:TMAN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TMAN has been successfully added to your 
